- Type / Class
- Equity / Common Stock
- Shares outstanding
- 415,460,499
- Total 13F shares
- 455,653,328
- Share change
- +11,516,685
- Total reported value
- $2,979,967,947
- Put/Call ratio
- 60%
- Price per share
- $6.54
- Number of holders
- 201
- Value change
- +$79,546,138
- Number of buys
- 115
- Number of sells
- 87
Quarterly Holders Quick Answers
What is CUSIP 00857U107?
CUSIP 00857U107 identifies AGL - agilon health, inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00857U107:
Top shareholders of AGL - agilon health, inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CD&R Investment Associates IX, Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
100,000,000
|
$1,122,000,000 | — | 18 May 2023 | |
| Clayton, Dubilier & Rice, LLC |
13F
|
Company |
24%
|
100,000,000
|
$610,000,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
15%
|
61,431,191
|
$374,730,265 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
14%
|
56,835,587
|
$346,697,082 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
13%
|
54,598,123
|
$333,048,557 | — | 31 Mar 2024 | |
| Capital World Investors |
13F
|
Company |
10%
|
42,397,780
|
$258,626,458 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
28,947,798
|
$176,581,568 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
4.9%
|
20,197,932
|
$123,207,385 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.4%
|
13,992,226
|
$85,352,581 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.1%
|
8,835,000
|
$53,893,500 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
5,184,889
|
$31,627,823 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
4,653,619
|
$28,393,300 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.98%
|
4,056,717
|
$24,745,974 | — | 31 Mar 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.61%
|
2,541,123
|
$15,500,852 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.53%
|
2,206,830
|
$13,461,663 | — | 31 Mar 2024 | |
| Daventry Group, LP |
13F
|
Company |
0.42%
|
1,750,249
|
$10,676,519 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.42%
|
1,727,986
|
$10,540,715 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.4%
|
1,665,762
|
$10,163,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.34%
|
1,412,995
|
$8,619,270 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.31%
|
1,302,004
|
$7,942,225 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
1,266,350
|
$7,724,735 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.29%
|
1,224,103
|
$7,467,028 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.29%
|
1,203,799
|
$7,343,174 | — | 31 Mar 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.26%
|
1,097,500
|
$6,694,750 | — | 31 Mar 2024 | |
| Durable Capital Partners LP |
13F
|
Company |
0.23%
|
976,133
|
$5,954,411 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
934,038
|
$5,697,633 | — | 31 Mar 2024 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.22%
|
900,547
|
$5,493,337 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
893,425
|
$5,449,893 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
707,246
|
$4,314,201 | — | 31 Mar 2024 | |
| Capital Research Global Investors |
13F
|
Company |
0.17%
|
697,385
|
$4,254,049 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.18%
|
737,647
|
$3,968,541 | — | 31 Mar 2024 | |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
162,286
|
$3,854,292 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
621,253
|
$3,789,644 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
602,800
|
$3,677,080 | — | 31 Mar 2024 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
0.14%
|
599,875
|
$3,659,238 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.14%
|
592,115
|
$3,611,902 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
584,522
|
$3,565,584 | — | 31 Mar 2024 | |
| NORTHWESTERN UNIVERSITY |
13F
|
Company |
0.14%
|
562,400
|
$3,431,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
555,918
|
$3,391,100 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.13%
|
545,793
|
$3,329,337 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.12%
|
506,242
|
$3,088,000 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.12%
|
496,172
|
$3,026,649 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.12%
|
487,738
|
$2,975,202 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.11%
|
476,689
|
$2,907,803 | — | 31 Mar 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.11%
|
470,759
|
$2,871,630 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
467,368
|
$2,850,945 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.1%
|
420,114
|
$2,562,695 | — | 31 Mar 2024 | |
| Veeral Desai |
3/4/5
|
Chief Strategy & Dev. Officer |
—
mixed-class rows
|
2,330,892
mixed-class rows
|
$2,465,164 | — | 14 Apr 2024 | |
| Advantage Alpha Capital Partners LP |
13F
|
Company |
0.09%
|
378,589
|
$2,309,393 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
371,353
|
$2,265,253 | — | 31 Mar 2024 |
Institutional Holders of agilon health, inc. - Common Stock (AGL) as of Q2 2024
As of 30 Jun 2024,
agilon health, inc. - Common Stock (AGL) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
455,653,328 shares.
The largest 10 holders included
Clayton, Dubilier & Rice, LLC, FMR LLC, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, Rock Springs Capital Management LP, and STATE STREET CORP.
This page lists
203
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
196
Q2 2024 holders
201
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.